Waterhemp and Palmer amaranth, two aggressive weeds that threaten the food supply in North America, are increasingly hard to kill with commercially available herbicides. A novel approach known as genetic control could one day reduce the need for these chemicals. Now, scientists are one step closer.
In a study published today in Weed Science, researchers from the University of Illinois identified genetic signatures that distinguish male waterhemp and Palmer amaranth plants from females. The discovery is a crucial part of developing a genetic control system for the damaging weeds.
The researchers’ goal is to one day introduce genetically modified male plants into a population to mate with wild females. Modified male plants would contain a gene drive, a segment of DNA coding for maleness, which would be passed on to all its offspring, and their offspring, and so on. Ultimately, all plants in a given population would become male, reproduction would cease, and populations would crash.
It’s a controversial strategy, but Pat Tranel, the U of I scientist leading the project, says they’re still in the very early stages.
“It’s important to emphasize that we are not at the point of releasing genetically modified waterhemp and Palmer. We are doing basic research that could inform how we could do that,” says Tranel, professor and associate head of the Department of Crop Sciences in the College of Agricultural, Consumer and Environmental Sciences at U of I.
He adds that the team hasn’t found the specific gene or genes for maleness in either species. Instead, they identified small genetic sequences associated with a male region, presumably on a particular chromosome. They think the specific gene(s) for maleness lies somewhere within that region.
In the study, the researchers grew 200 plants of each species and each sex, then extracted DNA and determined whether any sequences were unique to a given sex.
“We found sequences present in waterhemp and Palmer males that were not found in females, but no female-specific sequences. Then we took known males from other populations and looked for the sequences – they were there,” Tranel says. “Our sequences not only worked, they confirmed males are the heterogametic sex in these plants.”
In humans, males have an X and a Y chromosome, and male gametes, sperm, contribute either an X or a Y to the next generation. Females have two X chromosomes, and every egg carries an X. Males are heterogametic; females, homogametic. Similarly, male waterhemp and Palmer amaranth plants produce pollen with either the male-specific Y region or not.
“The fact that males are the heterogametic sex suggests that maleness is dominant. That’s good in that it’s easier to control the trait (maleness) if the gene for that trait is dominant,” Tranel explains. “When we get to the point of identifying the specific genes for maleness, they would be an obvious target for a gene drive where you could spread that maleness gene in the population.”
In the meantime, however, having a set of genetic sequences that can accurately identify males before flowering could help the researchers better understand the biology of the plants and their response to the environment. For example, Tranel says the discovery could help determine if the weeds are able to switch sexes under certain conditions or if one sex is more sensitive to herbicides. Both concepts have been proposed by previous research or anecdotal reports.
In addition to pursuing these basic questions, Tranel’s team is now working to find the needle in the haystack: the maleness gene within the male region. When they find it, it will take time before genetic control of waterhemp and Palmer amaranth could become a reality. And even then, Tranel says it will still be important to use all the tools in the weed management toolbox.
“I’d never see this as replacing all our other strategies,” he says. “But it’s super cool to imagine this as part of the solution.”
The Latest on: Genetic control
via Google News
The Latest on: Genetic control
- With Rare Speed, Gene Editing Emerges as Biotech’s New Cutting Edgeon January 14, 2021 at 12:15 pm
Cas9 that allow companies to edit DNA and attack genetic diseases and cancer are suddenly hot. But the science is moving with incredible speed and the competition is rising.
- LSU Health receives $2.5 million grant to reduce stroke risk for obese women taking birth control pillson January 14, 2021 at 10:12 am
The National Heart, Lung, and Blood Institute of the National Institutes of Health has awarded Rinku Majumder, PhD, Associate Professor of Biochemistry & Molecular Biology at LSU Health New Orleans ...
- GM plant grows insect sex pheromone compounds needed for green pest control in agricultureon January 14, 2021 at 8:17 am
ISCA, Inc., and their collaborators in Sweden have successfully ''grown'' insect sex pheromone precursors in genetically modified strains of camelina plants, creating a low-cost source of pheromones ...
- RoosterBio Partners with Sartorius to Advance Cell and Gene Therapy Manufacturingon January 14, 2021 at 7:00 am
RoosterBio's innovative hMSCs and bioprocess media systems, coupled with Sartorius's scalable closed system bioreactor, downstream processing, and analytics, offers ...
- Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeuticson January 13, 2021 at 3:30 pm
CAMBRIDGE, Mass., VANCOUVER, British Columbia, and BASEL, Switzerland, Jan 13, 2021 (GLOBE NEWSWIRE via COMTEX) -- -- Alliance will assess the use ...
- Lithium Resistance in Bipolar Tied to Deficient Gene Expressionon January 13, 2021 at 2:08 pm
A decrease in activation of the LEF1 gene may be the reason why many patients with bipolar disorder do not respond to lithium, considered the 'gold standard' treatment, new research suggests.
- New insights into the control of inflammationon January 13, 2021 at 11:01 am
Scientists at The Wistar Institute discovered that Early Growth Response 1 (EGR1), a protein that turns on and off specific genes during blood cell development, inhibits expression of pro-inflammatory ...
- East Bay gene therapy firm subleases out 153,000-square-foot manufacturing facilityon January 13, 2021 at 8:34 am
Gene therapy company Orchard Therapeutics plc, which last year shifted its manufacturing strategy from in-house to contractors, said Wednesday that it subleased the 153,000-square-foot manufacturing ...
- From Val Gene's to Cafe 501, Pete Holloway's legacy will endureon January 12, 2021 at 11:01 pm
"Jimmy and Gene taught me everything I know ... was the phrase I will remember him saying time and again. Who am I choosing to let control my emotions? He said it so often, my roommates and I went out ...
- Gene Therapy Leader Katherine High Joins AskBio as President, Therapeuticson January 12, 2021 at 10:46 pm
(AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company and wholly owned subsidiary of Bayer AG, today announced that Katherine High, MD, has joined the company in the newly ...
via Bing News